Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919590 · ClinicalTrials.gov registry record · NA
Text Message Quit Vaping Intervention for Adolescents
A NA study of Vaping and Cessation, Tobacco, sponsored by Truth Initiative.
- Completed
- Registry status
- NA
- Development phase
- 1,681
- Enrollment target
- 1
- Study location
NCT04919590: Completed NA study of Vaping and Cessation, Tobacco, sponsored by Truth Initiative.
NCT04919590 is a NA study of Vaping and Cessation, Tobacco that has completed, run by Truth Initiative. The registered enrollment target is 1,681 participants, above the 667-participant average among 18 other Vaping trials with a reported enrollment target (152% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04919590, a NA study of Vaping and Cessation, Tobacco, has completed, sponsored by Truth Initiative.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,681 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study, conducted by Truth Initiative, will help us learn how text messaging can help adolescents between 13 and 17 years of age quit vaping.
Primary Outcome
In the past 30 days, did you vape at all, even a puff of someone else's?
Conditions Studied
Interventions
- OTHER Waitlist control
- BEHAVIORAL This is Quitting
- OTHER Assessment only control
Study Locations (1)
District of Columbia
- Truth Initiative - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,681 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-10-18 |
| Phase | NA |
What the finished NCT04919590 record still lists
NCT04919590 is an interventional study that assigns participants to a tested intervention. Its 1,681 participants enrollment target places it among the larger protocols in the corpus, above the 667-participant average among 18 other Vaping trials with a reported enrollment target (152% higher).
The record links to 2 conditions, with Vaping appearing as the primary indexed condition, and to 3 interventions - of which Waitlist control is the first listed.
NCT04919590 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04919590 about?
NCT04919590 is a clinical study titled "Text Message Quit Vaping Intervention for Adolescents". This research study, conducted by Truth Initiative, will help us learn how text messaging can help adolescents between 13 and 17 years of age quit vaping.
What is the current status of trial NCT04919590?
This trial is currently completed. It is a NA study. The enrollment target is 1,681 participants. The study started on 2021-10-01. Estimated completion is 2023-10-18.
What conditions does trial NCT04919590 study?
This clinical trial studies the following conditions: Vaping, Cessation, Tobacco.
What interventions are being tested in trial NCT04919590?
The interventions under investigation include: Waitlist control (OTHER), This is Quitting (BEHAVIORAL), Assessment only control (OTHER).
Who is sponsoring clinical trial NCT04919590?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919590 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04919590's enrollment target sits among peer trials
1,681 3rd of 18 higher than 16 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI